The majority of cases of<unk><unk>  only require supportive care. Anti-thrombotic therapy is individualized based on patients' risk of developing thrombosis, which include aspirin therapy for low-risk patients and platelet lowering drugs (hydroxyurea, interferon-α and anagrelide) for high-risk patients.
Essential thrombocytosis medical therapy
Glanzmann's thrombasthenia medical therapy
Polycythemia vera medical therapy
Von Willebrand disease medical therapy
Disseminated intravascular coagulation medical therapy
Thrombotic thrombocytopenic purpura medical therapy
Heparin-induced thrombocytopenia medical therapy
Antithrombin III deficiency medical therapy